The Patent Finder
GT

Georgia Tech Research Corporation

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

860 patents currently held

159 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
13 more records may belong here and await a decision; they are not counted.

The next term ends in Dec 2026. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
89
Ending by 2030
Dec 2026
Next term end
699
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Capacitive Bulk Acoustic Wave Disk Gyroscopes US 7,543,496
Cited by 130 later US patents, top 5% of utility patents granted in 2009 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Ends Jun 2027 · High confidence
Also notable
Method for Drug Delivery to Ocular Tissue Using Microneedle US 7,918,814
The most cited patent in this portfolio, cited by 258 later US patents, top 5% of utility patents granted in 2011 in our data. Protection runs to 2029.
Ends Feb 2029 · High confidence
Also notable
Asymmetric Membrane Cmut Devices and Fabrication Methods US 7,646,133
Cited by 79 later US patents, top 10% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Ends Sep 2027 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 7 fees due Nov 21 to 30, 2026 · next Nov 21
  • 15 fees due Dec 4 to 27, 2026 · next Dec 4
  • 15 fees due Jan 2 to 30, 2027 · next Jan 2
  • 10 fees due Feb 1 to 27, 2027 · next Feb 1
  • 13 fees due Mar 5 to 24, 2027 · next Mar 5
  • 20 fees due Apr 3 to 30, 2027 · next Apr 3
  • 13 fees due May 3 to 26, 2027 · next May 3
  • 21 fees due Jun 1 to 30, 2027 · next Jun 1
  • 18 fees due Jul 5 to 30, 2027 · next Jul 5
  • 15 fees due Aug 2 to 27, 2027 · next Aug 2
  • 16 fees due Sep 1 to 26, 2027 · next Sep 1
  • 15 fees due Oct 9 to 30, 2027 · next Oct 9
  • 8 fees due Nov 3 to 17, 2027 · next Nov 3

Which patents, and when each one lapses · Pro

Recent changes

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 7,449,934CMOS Mixer for Use in Direct Conversion Receiver
In force
 · High confidence
In forceHigh confidence
US 8,008,835Multiple Element Electrode Cmut Devices and Fabrication Methods
In force
 · High confidence
In forceHigh confidence
US 7,627,459Systems and Methods for Reliability and Performability Assessment
In force
 · High confidence
In forceHigh confidence
US 8,858,489Conduit Device and System for Implanting a Conduit Device in a Tissue Wall
In force
 · High confidence
In forceHigh confidence
US 9,308,015Conduit Device and System for Implanting a Conduit Device in a Tissue Wall
In force
 · High confidence
In forceHigh confidence
US 9,950,146Conduit Device and System for Implanting a Conduit Device in a Tissue Wall
In force
 · High confidence
In forceHigh confidence
US 8,197,435Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle
In force
 · High confidence
In forceHigh confidence
US 8,636,713Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle
In force
 · High confidence
In forceHigh confidence
US 8,808,225Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle
In force
 · High confidence
In forceHigh confidence
US 10,905,586Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle
In force
 · Medium confidence
In forceMedium confidence
10 of 860 patents shown.
Pro members see all 860.
Pro members: see all 860 patents
Also on record, not counted in the 860: 159 patents in force now held by others · 762 patents ended · 618 applications pending · 511 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited